August 18, 2023
A New York federal judge on Friday confirmed an unopposed arbitration award against Janssen Pharmaceutical N.V. that required the Johnson & Johnson subsidiary to pay more than $194 million in back royalties to Alkermes Pharma Ireland Ltd., ending a legal dispute over licensing agreements between the companies.